Skip to content

Health Economics & Outcomes Research (HEOR)

Cytel is a Global Health Economics and Outcomes Research (HEOR) consultancy with a team of over 150+ HEOR consultants located in Europe, North America, and Asia-Pacific. We have a proven track record and a thorough multidisciplinary understanding of evolving local and global health technology assessment (HTA) requirements.

We pride ourselves on our scientific innovation, strategic multidisciplinary approach, flexibility to client needs, and tech-enabled solutions to pharmaceutical, biotech, and medical device clients across the product lifecycle.

Evidence Synthesis

Cytel’s HEOR services are committed to the high-evidentiary standards established by HTA bodies like NICE and closely following guidelines like PRISMA and those from Cochrane Collaboration. Our evidence synthesis team is multidisciplinary and consists of researchers with training across the spheres of health and medical sciences. 

Read more

Health Economic Modeling

Cytel’s global modeling team consists of modelers, biostatisticians, and multidisciplinary HEOR experts with a proven track record in developing economic models for successful HTA submissions globally, ranging from standard three-state partition survival oncology models to complex discrete event simulations for ultra-orphan indications.

Read more

HTA Trial Analyses

At the core of Cytel’s expertise is (advanced) trial data analyses which inform our models, our indirect treatment comparisons, value communication tools, and our reimbursement submission dossiers. Cytel is a demonstrated thought and methodology leader in improving data analytics and optimizing clinical trial data interpretation.

Read more

Value and Access

Cytel’s early value framework (EVF) provides a comprehensive evidence review and early economic modeling. We also offer complementary value and access services including patient-reported outcomes strategy, HTA submissions, and affiliate support and training.

Read more

Value Communication

Cytel’s world-class, highly experienced value communication consultants provide a full range of HEOR and market access communication offerings, including tailored product value propositions, global value dossiers (GVDs), Academy of Managed Care Pharmacy (AMCP) dossiers, HTA submissions, early scientific advice briefing books, infographics, white papers, and HEOR publication support.

Read more